Clinical Trial Update: A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on antenatal treatment for alloimmune thrombocytopenia, completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alloimmune Thrombocytopenia
• Fetal Alloimmune Thrombocytopenia

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Alloimmune Thrombocytopenia, Fetal Alloimmune Thrombocytopenia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-11-07